This Sources Sought opportunity from Department Of Veterans Affairs was posted on August 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Q301--New - QuantiFERON Testing Base + 4
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract establishes the procurement of blood collection tubes, reagents, and controls necessary to perform QuantiFERON-TB Gold Plus testing on the DiaSorin LIAISON XL instrument located at the VANTHCS facility in Dallas, Texas. The vendor is responsible for supplying all materials required for testing at no cost to the government and must ensure all procedures and equipment meet manufacturer specifications. Any failure resulting in testing being outsourced due to reagent shortages, equipment malfunction, or other vendor-caused issues will require the vendor to reimburse VANTHCS for associated costs. The vendor must immediately notify the facility of any changes to test composition, recalls, or procedural modifications in compliance with FDA regulations and provide detailed implementation guidance within 24 hours of any change. All supplies and reagents must be delivered as needed, with timely updates provided on backorders and invoices submitted monthly through specified channels for full accountability. The contract period runs from December 1, 2026, through November 30, 2027, with four optional one-year extensions through 2031. Performance is closely monitored through a Quality Assurance Surveillance Plan that sets measurable benchmarks for reagent reliability, peer comparison scores, invoice accuracy, backorder rates, customer service response times, and recall notifications. The vendor is held to strict quality thresholds, with failures in key areas such as repeat testing, peer performance, or complaint resolution potentially resulting in unsatisfactory ratings and impacting the exercise of option years. All records generated under the contract become the property of VANTHCS and must be returned at contract closeout. The vendor is prohibited from accessing any VA information systems or transferring VA data, maintaining a strict separation of responsibilities. Failure to meet any contractual obligations, including timely communication, regulatory compliance, or logistical support, will result in financial liability to the vendor without additional charges to the government.
General Info
Place of Performance
Department of Veterans Affairs VA North Texas Health Care, Dallas, TX, 75216, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
1.0 Purpose Request the procurement of supplies and reagent to perform QuantiFERON®- TB Gold Plus testing on the DiaSorin LIAISON XL instrument
2.0 Scope Vendor will provide blood collection tubes, reagents, and controls to perform testing utilizing the DiaSorin LIAISON XL instrument. 3.0 Location The instrument will be located, and testing will be performed in the Client Services and Immunopathology (CSI) section of the Pathology & Laboratory Medicine Service at the VANTHCS, 4500 S. Lancaster Rd, Dallas, TX 75216. 4.0 Performance
Test Performance: All tests, procedures, and equipment must perform at manufacturer s specifications. Deviations from the performance specifications shall be corrected by the Contractor. Test performance will be evaluated by and not limited for performance thru peer comparison, quality control and CAP peer evaluation. The vendor shall reimburse VANTHCS for any costs and/or supplies related to tests sent to a referral laboratory when testing is not available through no fault of the facility due to reagent problems, other product issues, instrumentation failure, or other factors. The assessed damages shall be applied to the invoice in the form of a credit or deduction. Safety: The Contractor shall immediately notify VANTHCS of any changes in reagent kit composition, procedure modification, recall notification, or any changes that will affect the performance of the test or procedure according to FDA regulations.
5.0 Period of Performance Cost per Test Purchase Agreement for supplies and reagents will be in effect from December 01, 2026 through November 30, 2027 with four additional option years.
Base Period: December 01, 2026 through November 30, 2027 Option 1: December 01, 2027 through November 30, 2028 Option 2: December 01, 2028 through November 30, 2029 Option 3: December 01, 2029 through November 30, 2030 Option 4: December 01, 2030 through November 30, 2031
6.0 Deliverables/Supplies Reagents and supplies will be purchased under the terms of the reagent purchase agreement. The Contractor shall deliver all supplies necessary for test performance at no Government cost. The Contractor shall provide supplies: reagents and consumables for test menu. In the event that requested supplies are on back-order, Contractor is to provide information as to the estimated time of availability. The Contractor shall deliver all invoices for review according to the established contract at the end of each billing cycle. All items not contracted shall be specifically detailed on the invoice including description, quantity acquired, and government cost. Any changes in reagents or equipment modifications shall be immediately disclosed by the Contractor electronically as well as by postal mail with supporting documentation of the change, and detailed guidance for implementation within twenty-four hours of its application. Additional charges incurred by the government to provide the continuity of contracted tests to patients and not limited to out sourcing, transportation, and or any other additional cost shall be covered by the Contractor at no additional charge to the government.
Sole Source Justification See form VHAPM Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Single Source Justification for SAP under the SAT.
8.0 Vendor Security Contract Requirements. This Contractor requires no access to VANTHCS or any VA information system.
NO VA DATA OF ANY TYPE SHALL BE TRANSFERRED FROM THE VA.
9. Records Management All records (administrative and program specific) created during the period of the contract belong to VA North Texas Health Care System (VANTHCS) and must be returned to VANTHCS at the end of the contract.
Quality Assurance Surveillance Plan (QASP) and its performance are as follows:
Standard Task Indicator Acceptable Quality Level Method of Surveillance Incentive Repeat runs are minimal due to reagent or instrument issues.
Schedule Successful reporting of results No more than 2 instances of repeat runs due to a single reagent or instrument issue per quarter. Exceptional: 0 Very Good: 1 Satisfactory: 2 Marginal: 3 Unsatisfactory: >3 Troubleshooting records Service records Exercise of Option Period Minimal unsuccessful performance due to instrument or reagent issues. Successful peer group comparison 90% satisfactory performance to peer group. Exceptional: 100% Very Good: 95-99% Satisfactory: 90-94% Marginal: 85-89% Unsatisfactory: <85% CAP survey reports Exercise of Option Period Telephone Support is responsive. Trouble-shooting via phone 95% Issues resolved within 3 calls or elevated to service. Exceptional: 100% Very Good: 98-99% Satisfactory: 95-97% Marginal: 85-89% Unsatisfactory: <85% Troubleshooting records Problem records Service records Exercise of Option Period Invoices are submitted monthly. Cost Control Invoice Accountability 100% Invoices received through OLCS via Austin, Texas Invoice records Exercise of Option Period Invoices are itemized by service or product received. Invoice Verification 80% Invoices contain all necessary information for proper processing. Excellent: 95-100% Very Good: 90-94% Satisfactory: 85-89% Marginal: 80-84% Unsatisfactory: <80% Invoice records Exercise of Option Period Backordered reagents and supplies are minimal. Backorders <5% Backorders per year. Excellent: 0% Very Good: 1-2% Satisfactory: 3-4% Marginal: 5% Unsatisfactory: >5% Order records Invoice records Customer communications Exercise of Option Period Provides timely follow-up for backorders. Management Backorder Notification 90% timely follow up for backorders Exceptional: 100% Very Good: 95-99% Satisfactory: 90-94% Marginal: 85-89% Unsatisfactory: <85% Order records Invoice records Customer communications Exercise of Option Period Contractor will provide proactive notification of changes. Notification of changes in reagent and equipment modifications 100% Proactive notifications.
Quality Bulletins Customer Letters Customer Contact Exercise of Option Period Timely recall notification of reagent and supplies. Regulatory
Recall Notification 100% Recall notifications within 1 month of issuance. Quality Bulletins Customer Letters Customer Contact Exercise of Option Period Works with customer to resolve complaints. Customer service Substantiated complaints No unresolved substantiated customer complaints per year Order records Invoice records Customer communications Problem records Troubleshooting records Exercise of Option Period Timely follow-up on complaints. Complaint Handling 90% Complaint follow-up within 24 hours of initial complaint or within agreed upon timeframe. Exceptional: 100% Very Good: 95-99% Satisfactory: 90-94% Marginal: 85-89% Unsatisfactory: <85% Order records Invoice records Customer communications Problem records Troubleshooting records Exercise of Option Period
More opportunities from Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS